NEW YORK (GenomeWeb) – GenDx announced that it has received Canadian ISO certification, enabling the firm to start the registration procedure for its Sanger and next-generation sequencing HLA reagents and software for diagnostic purposes in Canada.

Specifically, the Dutch molecular diagnostics firm said it received CAN/CSA ISO 13485:2003 certification, a standard that forms the basis for the Canadian Medical Devices Conformity Assessment System. The system was created by Health Canada and the Standards Council to implement Canada's medical devices regulations, Gendx noted.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.

Sep
27
Sponsored by
Philips Genomics

This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.

Sep
28
Sponsored by
Fabric Genomics

This webinar will discuss the critical role that software can play for clinical labs looking to establish comprehensive genomic testing programs.